U.S. markets closed
  • S&P Futures

    3,835.25
    +7.25 (+0.19%)
     
  • Dow Futures

    31,412.00
    +41.00 (+0.13%)
     
  • Nasdaq Futures

    12,810.50
    -21.25 (-0.17%)
     
  • Russell 2000 Futures

    2,197.50
    -2.50 (-0.11%)
     
  • Crude Oil

    63.09
    -0.44 (-0.69%)
     
  • Gold

    1,767.70
    -7.70 (-0.43%)
     
  • Silver

    27.32
    -0.36 (-1.32%)
     
  • EUR/USD

    1.2157
    -0.0030 (-0.24%)
     
  • 10-Yr Bond

    1.5180
    +0.1290 (+9.29%)
     
  • Vix

    28.89
    +7.55 (+35.38%)
     
  • GBP/USD

    1.3987
    -0.0026 (-0.18%)
     
  • USD/JPY

    106.2590
    +0.0290 (+0.03%)
     
  • BTC-USD

    47,448.07
    -2,670.28 (-5.33%)
     
  • CMC Crypto 200

    945.88
    -48.78 (-4.90%)
     
  • FTSE 100

    6,651.96
    -7.01 (-0.11%)
     
  • Nikkei 225

    29,506.96
    -661.31 (-2.19%)
     

New Strong Buy Stocks for December 16th

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Tirthankar Chakraborty
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Here are 4 stocks added to the Zacks Rank #1 (Strong Buy) List for today:

Vertex Pharmaceuticals Incorporated (VRTX): This company that engages in developing and commercializing therapies for treating cystic fibrosis has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.8% over the last 60 days.

Vertex Pharmaceuticals Incorporated Price and Consensus

 

Vertex Pharmaceuticals Incorporated Price and Consensus
Vertex Pharmaceuticals Incorporated Price and Consensus

Vertex Pharmaceuticals Incorporated price-consensus-chart | Vertex Pharmaceuticals Incorporated Quote

Gaming and Leisure Properties, Inc. (GLPI): This company that is engaged in the business of acquiring, financing, and owning real estate property has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.8% over the last 60 days.

Gaming and Leisure Properties, Inc. Price and Consensus

 

Gaming and Leisure Properties, Inc. Price and Consensus
Gaming and Leisure Properties, Inc. Price and Consensus

Gaming and Leisure Properties, Inc. price-consensus-chart | Gaming and Leisure Properties, Inc. Quote

The Charles Schwab Corporation (SCHW): This company that provides wealth management, securities brokerage, banking, asset management, custody, and financial advisory services has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.

The Charles Schwab Corporation Price and Consensus

 

The Charles Schwab Corporation Price and Consensus
The Charles Schwab Corporation Price and Consensus

The Charles Schwab Corporation price-consensus-chart | The Charles Schwab Corporation Quote

Zynerba Pharmaceuticals, Inc. (ZYNE): This clinical stage specialty pharmaceutical company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 18.7% over the last 60 days.

Zynerba Pharmaceuticals, Inc. Price and Consensus

 

Zynerba Pharmaceuticals, Inc. Price and Consensus
Zynerba Pharmaceuticals, Inc. Price and Consensus

Zynerba Pharmaceuticals, Inc. price-consensus-chart | Zynerba Pharmaceuticals, Inc. Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through Q3 2019, while the S&P 500 gained +39.6%, five of our strategies returned +51.8%, +57.5%, +96.9%, +119.0%, and even +158.9%.

This outperformance has not just been a recent phenomenon. From 2000 – Q3 2019, while the S&P averaged +5.6% per year, our top strategies averaged up to +54.1% per year.

See their latest picks free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Zynerba Pharmaceuticals, Inc. (ZYNE) : Free Stock Analysis Report
 
Vertex Pharmaceuticals Incorporated (VRTX) : Free Stock Analysis Report
 
The Charles Schwab Corporation (SCHW) : Free Stock Analysis Report
 
Gaming and Leisure Properties, Inc. (GLPI) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research